Loading...
Symbols:
Loading...
Symbols:
Schering-Plough Corp. (SGP)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Schering-Plough Corp. (SGP)
140 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on SGP
- SA Editor Miriam Metzinger(71)
- Mike Huckman(24)
- Jeffrey Saut(14)
- SA Editor Eli Hoffmann(12)
- Andrew Wilkinson(7)
Most popular authors
(tracked in watchlists)
- Philip Davis(566)
- Bespoke Investment Group(538)
- Trader Mark(459)
- SA Editor Eli Hoffmann(379)
- Andrew Wilkinson(305)
Most commented on authors
- SA Editor Eli Hoffmann(51)
- SA Editor Miriam Metzinger(38)
- SA Editor Joan Wickham(31)
- Mike Huckman(27)
- WaveNet Pharma (26)
- Hedge Fund Tracking: Lee Ainslie's Maverick Capital, Q3 2008
- Markets Strike Fresh Lows
- Hedge Fund Tracking: Thiel's Clarium Capital, Q3 2008
- How Pharma Is Faring in the Financial Crisis
- SEAS Prove Calming for Schering-Plough
- Wednesday Options Update: CHK, SJM, SGP, GE, YHOO & RL
- Are Pfizer and Lilly's ED Drugs Suffering from the Economic Slowdown?
- Big Pharma Feels Free Market Pain
- Earnings Preview: Schering-Plough
- Some Good News in Biotech
- Summer Surge for Pharma Powers IHE, but Concerns Remain
- Fannie, Freddie & Pharma: Does Resolution Help Sector Stocks?
- Schering Plough, Merck: Potential Cancer Concerns
- China's Hepatitis B Market to Double by 2012
- Is a Hurricane Lurking for Merck and Schering-Plough?
- Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
- Time to Invest in Pharmaceuticals?
- China Biotech Week in Review: Earnings, Earnings, Earnings
- Schering-Plough Takes Sole Possession of Its China JV
- Are Big Pharma's Dollar Days Nearly Over?
- Buying Healthcare Stocks for an Obama Presidency (Part III)
- 31 S&P 500 Stocks with Negative 3 FY Net Income
- So Much for the Summer Doldrums with Drugmakers
- Wall Street Breakfast: Must-Know News
- PowerShares FTSE RAFI Healthcare: Big Bets on Dow Dogs
- The State of Statins and Stents
- Merck/Schering-Plough's Heart Drug Couldn't Have Done Worse
- Clarifying the Vytorin Situation: Three Key Questions
- Wall Street Breakfast: Must-Know News
- Roche's Genentech Offer Sends Ripples Through Biotech
- Monday Options Outlook: SGP, MRK, AZN, AMGN, CELG, BBH, BAC, KRE, XLF
- Earnings Preview: Schering-Plough Corp.
- Will Lilly's Survey Have the Desired Effect on Cialis?
- Do Tell, Intel - Fast Money Recap (7/15/08)
- S&P's Poor Standard - Fast Money Recap (7/9/08)
- End of Quarter Window 'Un-dressing'
- FDA Stings Pharma, Big and Small
- Investing in Summer FUN-damentals: Nike, Urban Outfitters, Schering-Plough, Cedar Fair
- Saut: It's Time to Reduce 'Stuff' Stocks, Buy High Yielders
- Pharmaceutical Facts Investors Should Know
- Following the China Biopharma Beat
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »